White Matter Injury in Subarachnoid Hemorrhage in Humans

Chapter
First Online:
Part of the Springer Series in Translational Stroke Research book series (SSTSR, volume 4)

Abstract

The aim of this chapter is to give a succinct overview on white matter injury in aneurysmal subarachnoid hemorrhage (a SAH) in humans. Different mechanisms lead to white matter injury in aSAH: early brain injury, delayed brain injury, and hydrocephalus. The problem of white matter injury after SAH is a relatively understudied topic, and little is known about the specific mechanisms that cause damage.

Keywords

Middle Cerebral Artery External Ventricular Drain Delay Cerebral Ischemia Cytotoxic Edema White Matter Injury 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. Baldwin ME, Macdonald RL, Huo D et al (2004) Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke 35(11):2506–2511PubMedCrossRefGoogle Scholar
  2. De Marchis GM, Pugin D, Lantigua H et al (2013)Tonic-clonic activity at subarachnoid hemorrhage onset: impact on complications and outcome. PLoS One 8(8):e71405PubMedCrossRefGoogle Scholar
  3. de Rooij NK, Rinkel GJ, Dankbaar JW, Frijns CJ (2013) Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke 44(1):43–54PubMedCrossRefGoogle Scholar
  4. Del Bigio MR (2001) Pathophysiologic consequences of hydrocephalus. Neurosurg Clin N Am 12(4):639–649, viiPubMedGoogle Scholar
  5. Dorhout Mees SM, Rinkel GJ, Feigin VL et al (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (3): CD000277Google Scholar
  6. Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJE (2007) Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (4): CD00618Google Scholar
  7. Dorhout Mees SM, Algra A, Vandertop WP et al (2012) Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet 380(9836):44–49PubMedCrossRefGoogle Scholar
  8. Dreier JP (2011) The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 17(4):439–447PubMedCrossRefGoogle Scholar
  9. Fischer M, Dietmann A, Beer R et al (2013) Differential regulation of matrix-metalloproteinases and their tissue inhibitors in patients with aneurysmal subarachnoid hemorrhage. PloS one 8(3):e59952PubMedCrossRefGoogle Scholar
  10. Frontera JA, Fernandez A, Schmidt JM et al (2009) Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke 40(6):1963–1968PubMedCrossRefGoogle Scholar
  11. Gomis P, Graftieaux JP, Sercombe R, Hettler D, Scherpereel B, Rousseaux P (2010) Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage. J Neurosurg 112(3):681–688PubMedCrossRefGoogle Scholar
  12. Greenberg ED, Gold R, Reichman M et al (2010) Diagnostic accuracy of CT angiography and CT perfusion for cerebral vasospasm: a meta-analysis. AJNR Am J Neuroradiol 31(10): 1853–1860PubMedCrossRefGoogle Scholar
  13. Guo J, Shi Z, Yang K, Tian JH, Jiang L (2012) Endothelin receptor antagonists for subarachnoid hemorrhage. Cochrane Database Syst Rev (9): CD008354Google Scholar
  14. Jadhav V, Sugawara T, Zhang J, Jacobson P, Obenaus A (2008) Magnetic resonance imaging detects and predicts early brain injury after subarachnoid hemorrhage in a canine experimental model. J Neurotrauma 25(9):1099–1106PubMedCrossRefGoogle Scholar
  15. Jartti P, Karttunen A, Jartti A, Ukkola V, Sajanti J, Pyhtinen J (2004) Factors related to acute hydrocephalus after subarachnoid hemorrhage. Acta Radiol 45(3):333–339PubMedCrossRefGoogle Scholar
  16. Komotar RJ, Schmidt JM, Starke RM et al (2009) Resuscitation and critical care of poor-grade subarachnoid hemorrhage. Neurosurgery 64(3):397–410PubMedCrossRefGoogle Scholar
  17. Lee VH, Connolly HM, Fulgham JR, Manno EM, Brown RD, Wijdicks EFM (2006) Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg 105(2):264–270PubMedCrossRefGoogle Scholar
  18. Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P (1989) Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir 100(1–2):12–24PubMedCrossRefGoogle Scholar
  19. Mayer SA, Lin J, Homma S et al (1999) Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke 30(4):780–786PubMedCrossRefGoogle Scholar
  20. Petzold A, Keir G, Kay A, Kerr M, Thompson EJ (2006) Axonal damage and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 77(6):753–759PubMedCrossRefGoogle Scholar
  21. Sanchez-Pena P, Pereira AR, Sourour NA et al (2008) S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med 36(8):2267–2273PubMedCrossRefGoogle Scholar
  22. Saqqur M, Zygun D, Demchuk A (2007) Role of transcranial Doppler in neurocritical care. Crit Care Med 35(5 Suppl):S216–S223PubMedCrossRefGoogle Scholar
  23. Schmidt JM, Rincon F, Fernandez A et al (2007) Cerebral infarction associated with acute subarachnoid hemorrhage. Neurocrit Care 7(1):10–17PubMedCrossRefGoogle Scholar
  24. Senbokuya N, Kinouchi H, Kanemaru K et al (2013) Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial. J Neurosurg 118(1):121–130PubMedCrossRefGoogle Scholar
  25. Suarez JI, Tarr RW, Selman WR (2006) Aneurysmal subarachnoid hemorrhage. N Eng J Med 354(4):387–396CrossRefGoogle Scholar
  26. van Asch CJJ, van der Schaaf IC, Rinkel GJE (2010) Acute hydrocephalus and cerebral perfusion after aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 31(1):67–70PubMedCrossRefGoogle Scholar
  27. van Gijn J, Hijdra A, Wijdicks EF, Vermeulen M, van Crevel H (1985) Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg 63(3):355–362PubMedCrossRefGoogle Scholar
  28. Vergouwen MDI, de Haan RJ, Vermeulen M, Roos YBWEM (2010) Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke 41(1):e47–e52PubMedCrossRefGoogle Scholar
  29. Wartenberg KE, Sheth SJ, Michael Schmidt J et al (2010) Acute ischemic injury on diffusion-weighted magnetic resonance imaging after poor grade subarachnoid hemorrhage. Neurocrit Care 14(3):407–415CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Division of Neurocritical Care, Department of NeurologyNew York Presbyterian Hospital/Columbia University Medical CenterNew YorkUSA

Personalised recommendations